Gallery    Site Map    Feedback    Careers
NGRATHI APP
18 Jul, 2018, 01:05:58 AM
BSE NSE
SENSEX
36,519.96 196.19
Nifty
11,008.05 71.20
BSE Announcements
As on : 16-Jul-2018 Your Result on : Equity | Corporate Actions | BSE Announcements
Corporate Events filed by the Companies to the BSE Stock Exchange.
Bayer Crop Sci.
Bayer CropScience will hold a meeting of the Board of Directors of the Company on 26 July 2018, to take on record the Unaudited Financial Results of the Company for the quarter ended on June 30, 2018.
Carborundum Uni.
Carborundum Universal has allotted 22,132 shares of Re.1/- each arising out of the exercise of stock options, granted to the option grantees of the Company under the Employees Stock Option Scheme 2007 on 14 July 2018.

With this allotment the number of equity shares outstanding is 189,039,103 and the paid-up equity share capital is Rs.189,039,103/-.

Excel Inds.
Excel Industries announced that the Annual General Meeting (AGM) of the company will be held on 9 August 2018.
H D F C
Housing Development Finance Corporation announced that the Allotment Committee of the Corporation at its meeting held on 14 July2 018 has approved the allotment of 51,03,814 equity shares of Rs 2 each on conversion of warrants.
M M Rubber
MM Rubber Co will hold a meeting of the Board of Directors of the Company on 13 August 2018.
Tata Power Co.
Tata Power Company will hold a meeting of the Board of Directors of the Company on 26 July 2018.
TRF
TRF will hold a meeting of the Board of Directors of the Company on 27 July 2018. to consider, approve and take on record the standalone and consolidated financial results for the quarter ended June 30, 2018.
NESCO
NESCO announced that the 59th Annual General Meeting (AGM) of the company will be held on 8 August 2018.
Dr Reddy's Labs
Dr Reddy's Laboratories announced its intent to appeal the decision made by the U.S. District Court for the District of New Jersey in a preliminary injunction hearing with respect to further sales and commercialization of Dr. Reddy's Buprenorphine and Naloxone Sublingual Film within the United States.

The company disagrees with the court's decision, and will vigorously appeal it.

Dr. Reddy's had announced the receipt of the approval, on June 15, 2018 by one of its wholly owned subsidiaries, from the U.S. Food and Drug Administration (USFDA) for its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, therapeutic equivalent generic version of Suboxone® (buprenorphine and naloxone) sublingual film, in the United States market.

Lime Chemicals
The Board of Lime Chemicals at its meeting held on 16 July 2018 has allotted 16,25,000 equity shares of Rs 10 each on conversion of warrants.